OECD Home › Directorate for Financial and Enterprise Affairs › Publications & Documents › Publications
English, PDF, 236kb
This statement was adopted by National Contact Points on 25 June 2014 during their 15th Meeting.
English, PDF, 5,607kb
Este folleto contiene información esencial sobre las Líneas Directrices de la OCDE para empresas multinacionales, que en la actualidad constituyen las recomendaciones más exhaustivas aprobadas por los gobiernos sobre la conducta responsable de las empresas.
English, PDF, 443kb
This report describes the key findings from responses by 35 countries to a survey on implicit guarantees. Policy makers have announced their intention to rein in the values of implicit guarantees so it is important to measure their value to help facilitate the task of assessing progress in reducing their value.
This Investment Policy Review examines Mauritius's achievements in developing an open and transparent investment regime and its efforts to reduce restrictions on international investment.
This page contains all information relating to implementation of the OECD Anti-Bribery Convention in Mexico.
Entry by generic pharmaceuticals can enhance competition, but innovation should be, at the same time, enhanced by allowing innovators to obtain intellectual property rights on their originator drug. The Competition Committee discussed these issues in June 2014.